Another Recommendation On Wall Street for Voyager Therapeutics Inc (VYGR). This time with a $35.0 Share Target PriceDecember 16, 2017 - By Peter EricksonWhy Has Raymond James Given Voyager Therapeutics Inc (VYGR) a $35.0 Price TargetIn a research note revealed to clients today, Raymond James analysts has begun Voyager Therapeutics Inc (VYGR) coverage with “Buy” rating, and a $35.0 TP. Voyager Therapeutics, Inc. (NASDAQ:VYGR) Ratings CoverageAmong 9 analysts covering Voyager Therap… (VYGR), 8 have Buy rating, 0 Sell and 1 Hold. After $-0.89 actual earnings per share reported by Voyager Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -14.61 % EPS growth. More recent Voyager Therapeutics, Inc. (NASDAQ:VYGR) news were published by: Quotes.Wsj.com which released: “Voyager Therapeutics Inc.” on November 06, 2015.

Source: Wall Street Journal December 16, 2017 15:56 UTC